Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Interest & Investment Income (2020 - 2025)

DarioHealth filings provide 6 years of Interest & Investment Income readings, the most recent being $242000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 50.31% to $242000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $943000.0, a 15.5% decrease, with the full-year FY2025 number at $943000.0, down 15.5% from a year prior.
  • Interest & Investment Income hit $242000.0 in Q4 2025 for DarioHealth, up from $175000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $470000.0 in Q4 2023 to a low of $4000.0 in Q1 2022.
  • Median Interest & Investment Income over the past 5 years was $207000.0 (2022), compared with a mean of $186200.0.
  • Biggest five-year swings in Interest & Investment Income: tumbled 74.29% in 2021 and later surged 1625.0% in 2022.
  • DarioHealth's Interest & Investment Income stood at $12000.0 in 2021, then surged by 1625.0% to $207000.0 in 2022, then surged by 127.05% to $470000.0 in 2023, then plummeted by 65.74% to $161000.0 in 2024, then soared by 50.31% to $242000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $242000.0 (Q4 2025), $175000.0 (Q3 2025), and $237000.0 (Q2 2025) per Business Quant data.